Bolt Biotherapeutics, Inc. Current State and Local Tax Expense (Benefit)
Bolt Biotherapeutics, Inc. (BOLT) reported Current State and Local Tax Expense (Benefit) of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2024-03-21
- Bolt Biotherapeutics, Inc. current state and local tax expense (benefit) for fiscal 2023 was $0.00.
- Bolt Biotherapeutics, Inc. current state and local tax expense (benefit) for fiscal 2022 was $0.00.
- Bolt Biotherapeutics, Inc. current state and local tax expense (benefit) for fiscal 2021 was $0.00.
- Bolt Biotherapeutics, Inc. current state and local tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |